# Efficacy of Sodium Polystyrene Sulfonate in the Treatment of Hyperkaliemia in Pre-dialysis Patients

> **NCT02065076** · PHASE4 · COMPLETED · sponsor: **Maisonneuve-Rosemont Hospital** · enrollment: 38 (estimated)

## Conditions studied

- Hyperkalemia
- Chronic Kidney Failure

## Interventions

- **DRUG:** Sodium polystyrene sulfonate
- **DRUG:** Lactose with carob gum

## Key facts

- **NCT ID:** NCT02065076
- **Lead sponsor:** Maisonneuve-Rosemont Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2014-09
- **Final completion:** 2014-10
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2014-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02065076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02065076, "Efficacy of Sodium Polystyrene Sulfonate in the Treatment of Hyperkaliemia in Pre-dialysis Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02065076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*